4 resultaten
The present application is the national stage under 35 U.S.C. .sctn.371 of international application PCT/JP99/06473, filed 19 Nov. 1999 which designated the United States, and which application was not published in the English language.
FIELD OF THE INVENTION
The present invention relates to
FIELD OF THE INVENTION
This invention relates to the evaluation of fertility and monitoring of early pregnancy, fetal development, placental development and function, parturition, and conditions such as pre-eclampsia, intrauterine growth restriction (IUGR), early abortion and abnormal uterine
TECHNICAL FIELD
The present invention relates to a pharmaceutical composition for the treatment, prevention and diagnosis of a disease selected from the group consisting of perinatal diseases, cancer, nervous system diseases, inflammatory diseases, cardiovascular diseases, endocrine diseases, viral
BACKGROUND OF THE INVENTION
This invention relates to the application of recombinant DNA technology to plants, specifically for the purpose of achieving male sterility.
The production of hybrids via sexual hybridisation of parents with differing genetic backgrounds is an important practice in modern